Dudediligence.

Ligand Pharmaceuticals Incorporated

LGNDNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$34.7M

25 notices · 135,952 sh

Nov 2025 to Oct 2026

Reported ·

$17.1M

99 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

82 of 99 reported sales carry the 10b5-1 box. Together they are 0.39% of the shares on issue.

PLANNED · FORM 144Nov 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-10: MARTINE ZIMMERMANN, Form 1442026-09-03: ANDREW REARDON, Form 1442026-08-12: OCTAVIO ESPINOZA, Form 1442026-08-12: Jason Haas, Form 1442026-07-01: ANDREW REARDON, Form 1442026-06-16: STEPHEN L. SABBA, Form 1442026-06-12: JASON HAAS, Form 1442026-06-11: Aryeh Jason, Form 1442026-06-10: Aryeh Jason, Form 1442026-06-10: JOHN L LAMATTINA, Form 1442026-06-10: Aryeh Jason, Form 1442026-05-13: JOHN KOZARICH, Form 1442026-05-12: JOHN KOZARICH, Form 1442026-05-01: KOZARICH JOHN W, Form 1442026-04-01: KOZARICH JOHN W, Form 1442026-03-23: STEPHEN L. SABBA, Form 1442026-03-11: OCTAVIO ESPINOZA, Form 1442026-03-06: JOHN L LAMATTINA, Form 1442026-03-04: ANDREW REARDON, Form 1442026-03-04: OCTAVIO ESPINOZA, Form 1442026-03-03: STEPHEN L. SABBA, Form 1442026-02-02: KOZARICH JOHN W, Form 1442026-01-02: KOZARICH JOHN W, Form 1442025-12-12: OCTAVIO ESPINOZA, Form 1442025-12-01: KOZARICH JOHN W, Form 1442025-11-03: KOZARICH JOHN W, sold2025-11-07: LAMATTINA JOHN L, sold2025-11-07: Gray Nancy Ryan, sold2025-12-01: KOZARICH JOHN W, sold2025-12-12: Espinoza Octavio, sold2026-01-02: KOZARICH JOHN W, sold2026-02-02: KOZARICH JOHN W, sold2026-03-02: KOZARICH JOHN W, sold2026-03-03: Sabba Stephen L, sold2026-03-04: Espinoza Octavio, sold2026-03-04: Reardon Andrew, sold2026-03-06: LAMATTINA JOHN L, sold2026-03-11: Espinoza Octavio, sold2026-03-23: Sabba Stephen L, sold2026-04-01: Reardon Andrew, sold2026-04-01: KOZARICH JOHN W, sold2026-05-01: Reardon Andrew, sold2026-05-01: KOZARICH JOHN W, sold2026-06-01: Reardon Andrew, sold2026-06-10: LAMATTINA JOHN L, sold2026-06-10: Aryeh Jason, sold2026-06-12: Haas Jason, sold2026-06-16: Sabba Stephen L, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-10MARTINE ZIMMERMANN, Director$342,000
1,200 shno plan dateForm 4s on file end Jun 23144 ↗
2026-09-03ANDREW REARDON, CLO & Secretary$4,303,800
15,000 shplan 2026-06-04Form 4s on file end Jun 23144 ↗
2026-08-12OCTAVIO ESPINOZA, Chief Financial Officer$9,136,339
31,641 shplan 2026-05-13Form 4s on file end Jun 23144 ↗
2026-08-12Jason Haas, Director$2,090,062
7,138 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-01ANDREW REARDON, CLO & Secretary$3,160,900
10,000 shplan 2025-11-24Form 4s on file end Jun 23144 ↗
2026-06-16STEPHEN L. SABBA, Director$544,830
2,145 shno plan date144 ↗
Form 4, 2026-06-18: sold 2,145 at $254.00 Form 4 ↗
2026-06-12JASON HAAS, Director$1,654,016
6,461 shno plan date144 ↗
Form 4, 2026-06-15: sold 6,461 at $255.58 Form 4 ↗
2026-06-11Aryeh Jason, Director$1,124,880
4,500 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-10Aryeh Jason, Director$124,980
500 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-10JOHN L LAMATTINA, Director$1,133,711
4,519 shno plan date144 ↗
Form 4, 2026-06-12: sold 4,591 at $250.88 Form 4 ↗
2026-06-10Aryeh Jason, Director$1,246,750
5,000 shno plan date144 ↗
Form 4, 2026-06-12: sold 5,000 at $250.00 Form 4 ↗
2026-05-13JOHN KOZARICH, Director$352,013
1,575 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-12JOHN KOZARICH, Director$102,816
459 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-01KOZARICH JOHN W, Director$107,349
467 shplan 2025-03-07144 ↗
Form 4, 2026-05-14: sold 2,501 at $225.14 Form 4 ↗
2026-04-01KOZARICH JOHN W, Director$95,035
467 shplan 2025-03-07144 ↗
Form 4, 2026-04-02: sold 467 at $202.22 Form 4 ↗
2026-03-23STEPHEN L. SABBA, Director$207,873
1,000 shno plan date144 ↗
Form 4, 2026-03-25: sold 1,000 at $207.87 Form 4 ↗
2026-03-11OCTAVIO ESPINOZA, Chief Financial Officer$648,971
3,057 shplan 2025-11-19144 ↗
Form 4, 2026-03-13: sold 3,057 at $225.00 Form 4 ↗
2026-03-06JOHN L LAMATTINA, Director$433,842
2,161 shno plan date144 ↗
Form 4, 2026-03-31: sold 2,161 at $200.76 Form 4 ↗
2026-03-04ANDREW REARDON, CLO & Secretary$4,084,800
20,000 shplan 2025-11-24144 ↗
Form 4, 2026-03-06: sold 5,000 at $206.35 Form 4 ↗
2026-03-04OCTAVIO ESPINOZA, Chief Financial Officer$2,741,514
13,423 shplan 2025-11-19144 ↗
Form 4, 2026-03-06: sold 13,423 at $205.83 Form 4 ↗
2026-03-03STEPHEN L. SABBA, Director$409,851
2,034 shno plan date144 ↗
Form 4, 2026-03-05: sold 2,034 at $201.50 Form 4 ↗
2026-02-02KOZARICH JOHN W, Director$89,748
467 shplan 2025-03-07144 ↗
Form 4, 2026-02-04: sold 467 at $195.91 Form 4 ↗
2026-01-02KOZARICH JOHN W, Director$88,076
467 shplan 2025-03-07144 ↗
Form 4, 2026-01-06: sold 467 at $189.58 Form 4 ↗
2025-12-12OCTAVIO ESPINOZA, Chief Financial Officer$339,711
1,804 shno plan date144 ↗
Form 4, 2025-12-16: sold 1,804 at $188.31 Form 4 ↗
2025-12-01KOZARICH JOHN W, Director$93,344
467 shplan 2025-03-07144 ↗
Form 4, 2025-12-03: sold 467 at $195.84 Form 4 ↗